Acute Bronchitis Clinical Trial
Official title:
Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis: a Phase 2, Double-blind, Randomized Placebo-controlled Trial
This study is a phase 2, multicentre, dose-finding, double-blind, randomized placebo-controlled trial to evaluate the efficacy and safety of two different doses of GHX02, compared with placebo, for acute bronchitis. One-hundred and fifty patients will be included in this trial and randomly assigned to either a high-dose GHX02 group(1920mg/day), standard-dose GHX02 group(960mg/day), or control group(placebo) in a 1:1:1 allocation ratio. Patients will take one of the medications three times a day for 7 days, with 3 visiting days(screening, day0, day7). On the screening day, the Korean Standard Tool of Pattern Identification of Cough and Sputum, a diagnostic system that determines therapy in Traditional Korean Medicine, will be used to allocate patients into three groups of wind-heat, wind-cold or others.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03711292 -
Using Behavioral Science to Reduce Inappropriate Antibiotic Use in Acute Care Settings
|
N/A | |
| Not yet recruiting |
NCT03517215 -
The Development and Testing of a Scaling Strategy for a Community-Based Primary Care Antimicrobial Stewardship Program
|
N/A | |
| Completed |
NCT01420445 -
Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis
|
Phase 2 | |
| Completed |
NCT00360464 -
A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases
|
Phase 3 | |
| Completed |
NCT05344638 -
A Clinical Trial to Evaluate the Safety and Efficacy of "AG1904" in Acute Bronchitis
|
Phase 3 | |
| Completed |
NCT04239521 -
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
|
||
| Recruiting |
NCT03827590 -
Clinical Trials to Assess the Efficacy and Safety of HLIM
|
Phase 3 | |
| Completed |
NCT02792946 -
Compare the Efficacy and Safety of Surfolase CR Tablet With Surfolase Capsule in Patients With Acute Bronchitis
|
Phase 3 | |
| Completed |
NCT01875757 -
Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life
|
Phase 3 | |
| Recruiting |
NCT04252963 -
Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)
|
Phase 4 | |
| Completed |
NCT01416480 -
Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute Cougher
|
Phase 3 | |
| Enrolling by invitation |
NCT05916768 -
Management of Acute Bronchitis With Pelargonium Sidoides Extract
|
N/A | |
| Completed |
NCT03309800 -
A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Placebo in Acute Bronchitis Patients
|
Phase 2 | |
| Completed |
NCT02250027 -
A Multicenter, Randomized, Double-blind, Parallel Group Study to Determine the Optimal Dose of HL301 After 7 Days Oral Administration in Acute Bronchitis or Acute Exacerbations of Chronic Bronchitis Patients (HL301: Mixed Extract of Rehmannia Glutinosa, Schisandra and so on)
|
Phase 2 | |
| Completed |
NCT03654196 -
A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Umkamin Tab in Acute Bronchitis Patients
|
Phase 3 | |
| Completed |
NCT03011515 -
Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI)
|
||
| Completed |
NCT02045394 -
Epidemiology and Diagnosis of Haemoptysis: a Multicenter Study
|
N/A | |
| Completed |
NCT01800747 -
Clinical Trial for the Assessment of Delayed Antibiotic Treatment in Pediatric (DAP-Pediatrics)
|
Phase 4 | |
| Recruiting |
NCT06142994 -
Treatment of Adults With Acute Bronchitis in the Primary Healthcare Setting
|
N/A | |
| Completed |
NCT05337163 -
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
|